Evidence map›Paper›PMID 35534903›Full record

Trial reportTrials2022

High-flow nasal cannula versus standard low-flow nasal cannula during deep sedation in patients undergoing radiofrequency atrial fibrillation catheter ablation: a single-centre randomised controlled trial.

Marloes C Homberg, Esther A Bouman, Dominik Linz, Sander M J van Kuijk, Bert A Joosten, Wolfgang F Buhre

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04842253 (High Flow Nasal Cannula), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04842253 naterminatednot on this map

High Flow Nasal Cannula (HFNC) Versus Standard Low Flow Nasal Cannula (LFNC) in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation (RFCA) Under Deep Desaturation.

TypeinterventionalSponsorMaastricht University Medical CenterRan2022 to 2024Enrolled141ConditionsDeep Sedation, Oxygen Therapy, Radiofrequency AblationArmsHigh flow nasal cannula
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Marloes C HombergDepartment of Anaesthesiology and Pain Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands. marloes.homberg@mumc.nl.ORCID http://orcid.org/0000-0003-2286-2763
Esther A BoumanDepartment of Anaesthesiology and Pain Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Dominik LinzDepartment of cardiology, Maastricht University Medical Centre and cardiovascular research institute Maastricht, Maastricht, the Netherlands.
Sander M J van KuijkDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, the Netherlands.
Bert A JoostenDepartment of Anaesthesiology and Pain Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Wolfgang F BuhreDepartment of Anaesthesiology and Pain Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Maastricht University Medical Centre · NLUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo our knowledge, there are few trials studying the effect of high-flow nasal cannula (HFNC) during deep sedation. Our hypothesis is that high-flow nasal cannula (HFNC) will prevent hypoxemia and desaturation as compared to low-flow nasal cannula (LFNC) during prolonged deep sedation in patients with atrial fibrillation undergoing radiofrequency catheter ablation (RFCA).

methodsA single-centre, randomised controlled trial with HFNC as the intervention and LFNC as the control group. A total of 94 adult patients per group undergoing elective radiofrequency atrial fibrillation catheter ablation under deep sedation. will be included. The primary outcome is the lowest oxygen saturation (SpO DISCUSSION: HFNC is increasingly used as a technique for oxygen delivery in procedural sedation and analgesia. We hypothesise that HFNC is superior to the standard treatment LFNC in patients under deep sedation with respect to the incidence of desaturation. To our knowledge, there are no adequately powered clinical trial studies on the effects of HFNC in prolonged deep sedation.

trial registrationClinicalTrials.gov NCT04842253. Registered on 04 April 2021.

Indexed as

Atrial FibrillationCatheter AblationDeep SedationAdultCannulaCarbon DioxideHumansOxygenOxygen Inhalation TherapyCarbon DioxideOxygenAnaesthesiologyAtrial fibrillationDeep sedationHigh-flow nasal cannulaRadiofrequency catheter ablationRandomised controlled trialSedation

Identifiers

PMID35534903
PMCPMC9082831
OpenAlexW4229376110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.